Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia

Leukemia

Volumn 14, Issue 8, 2000, Pages 1426-1435

  Verhagen, O J H M ^a   Willemse, M J ^b   Breunis, W B ^a   Wijkhuijs, A J M ^b   Jacobs, D C H ^b   Joosten, S A ^b   Van Wering, E R ^c   Van Dongen, J J M ^b   Van Der Schoot, C E ^d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c DUTCH CHILDHOOD ONCOLOGY GROUP   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Acute lymphoblastic leukemia (ALL); Germline J(H) TaqMan probes; IGH gene rearrangements; Minimal residual disease (MRD); Real time quantitative PCR (RQ PCR)

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; OLIGONUCLEOTIDE; T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ARTICLE; CANCER CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; GENE REARRANGEMENT; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; THERMOREGULATION;

EID: 0033894921     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401801     Document Type: Article

References (39)

1. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
2. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer - Childhood Leukemia Cooperative Group
3. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
4. Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome
5. Detection of minimal residual disease in acute leukemia patients
6. Improved detection of minimal residual leukemia through modifications of polymerase chain reaction analyses based on clonospecific T cell receptor junctions
7. IgH/TCR delta PCR oligonucleotide liquid hybridization, a fast and sensitive assay for monitoring minimal residual disease in childhood B-precursor ALL
8. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: Report of the BIOMED-1 Concerted A
9. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: Implications for selection of PCR targets for detection of minimal residual disease
10. Cross-lineage T-cell receptor gene rearrangement occur in more than ninety percent of childhood precursor-B-acute lymphoblastic leukemias: Alternative PCR targets for detection minimal residual disease
11. Quantitative PCR techniques and applications
12. Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study delta and gamma T-cell receptor genes
13. Quantitation of targets for PCR by use of limiting dilution
14. Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: A description of the method and the principles involved
15. Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia
16. Real time quantitative PCR
17. Detection of specific polymerase chain reaction product by utilizing the 5'-3' 3' exonuclease activity of Thermus aquaticus DNA polymerase
18. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes
19. Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR
20. Novel 5' exonuase-based real-time PCR assay for the detection t(14;18)(q32;q21) in patients with follicular lymphoma
21. Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay
22. Rapid and sensitive minimal residual disease detection in acute leukemia quantitative real-time RT-PCR exemplified by t(12;21) TEL-AM fusion transcript
23. Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR
24. Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques
25. Analysis of immunoglobulin and T cell receptor genes. Part I: Basic and technical aspects
26. Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis. Recommendations for optimal results
27. Rearrangement status of the malignant cell determines type of secondary IgH rearrangement (V-replacement or V to DJ joining) in childhood B precursor acute lymphoblastic leukemia
28. Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant D(H)6-19 and D(H)7-27 gene usage, can result in complete V-D-J rearrangements. and are rare in T-cell receptor αβ lineage
29. A consensus strategy to quantitate malignant cells in Myeloma patients validated in a multicentre study
30. The human immunoglobulin VH repertoire
31. A complete map of the human immunoglobulin VH locus
32. Sequence of the human immunoglobulin diversity (D) segment locus: A systematic analysis provides no evidence for the use of DIR segments, inverted D segments, 'minor' D segments or D-D recombination
33. Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia
34. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: Implications for the detection of minimal residual disease by polymerase chain reaction analysis
35. A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia
36. Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions
37. Predominance of fetal type DJH joining in young children with B precursor lymphoblastic leukemia as evidence for an in utero transforming event
38. Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes
39. B precursor acute lymphoblastic leukemia third complementarity-determining regions predominantly represent an unbiased recombination repertoire: Leukemic transformation frequently occurs in fetal life